Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Greenberg

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Medical Economics|May 20, 2009
Does generic substitution always make sense?Paul E Greenberg
Pharmacoeconomics|September 11, 2014
Cost of illness: an ongoing battle worth fightingPaul E Greenberg
Pharmacoeconomics|May 13, 2021
Introduction to the Special Issue of PharmacoEconomics on Major Depressive DisordersPaul E Greenberg, Tammy Sisitsky
Expert Opinion on Pharmacotherapy|March 30, 2005
The economic burden of depression in the US: societal and patient perspectivesPaul E Greenberg, Howard G Birnbaum
Pharmacoeconomics|September 14, 2010
Introducing perspectives on comparative effectiveness researchHoward G Birnbaum, Paul E Greenberg
Pharmacoeconomics|October 20, 2009
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturersPaul E Kalb, Paul E Greenberg
Health Affairs (Project Hope)|February 11, 2012
Confounding factors in off-label drug usePaul E Greenberg, Crystal Pike, Tammy Sisitsky
Pharmacoeconomics|September 14, 2010
Perspectives on comparative effectiveness research: views from diverse constituenciesDave Nellesen, Howard G Birnbaum, Paul E Greenberg
Journal of Affective Disorders|March 21, 2003
The economics of women and depression: an employer's perspectiveHoward G Birnbaum, Stephanie A Leong, Paul E Greenberg
Chest|August 13, 2002
Economic burden of respiratory infections in an employed populationHoward G Birnbaum, Melissa Morley, Paul E Greenberg, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|May 20, 2009
Does generic substitution always make sense?Paul E Greenberg
Pharmacoeconomics|September 11, 2014
Cost of illness: an ongoing battle worth fightingPaul E Greenberg
Pharmacoeconomics|May 13, 2021
Introduction to the Special Issue of PharmacoEconomics on Major Depressive DisordersPaul E Greenberg, Tammy Sisitsky
Expert Opinion on Pharmacotherapy|March 30, 2005
The economic burden of depression in the US: societal and patient perspectivesPaul E Greenberg, Howard G Birnbaum
Pharmacoeconomics|September 14, 2010
Introducing perspectives on comparative effectiveness researchHoward G Birnbaum, Paul E Greenberg
Pharmacoeconomics|October 20, 2009
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturersPaul E Kalb, Paul E Greenberg
Health Affairs (Project Hope)|February 11, 2012
Confounding factors in off-label drug usePaul E Greenberg, Crystal Pike, Tammy Sisitsky
Pharmacoeconomics|September 14, 2010
Perspectives on comparative effectiveness research: views from diverse constituenciesDave Nellesen, Howard G Birnbaum, Paul E Greenberg
Journal of Affective Disorders|March 21, 2003
The economics of women and depression: an employer's perspectiveHoward G Birnbaum, Stephanie A Leong, Paul E Greenberg
Chest|August 13, 2002
Economic burden of respiratory infections in an employed populationHoward G Birnbaum, Melissa Morley, Paul E Greenberg, et al.
Pageof 4